Skip to main content
. 2023 Feb 1;34(2):89–100. doi: 10.5152/tjg.2023.22239

Figure 1.

Figure 1.

Algorithm for the management of PBC patients with disease-modifying agents. PBC, primary biliary cholangitis; UDCA, ursodeoxycholic acid; ALP, alkaline phosphatase; ULN, upper limit of normal.